Skip to content
RDL Network logo
Effect of <scp>RNS60</scp> in amyotrophic lateral sclerosis: a phase <scp>II</scp> multicentre, randomized, double‐blind, placebo‐controlled trial — Ettore Beghi (2022) | RDL Network